Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 294

1.

Facilitated bone mineral density testing versus hospital-based case management to improve osteoporosis treatment for hip fracture patients: additional results from a randomized trial.

Morrish DW, Beaupre LA, Bell NR, Cinats JG, Hanley DA, Harley CH, Juby AG, Lier DA, Maksymowych WP, Majumdar SR.

Arthritis Rheum. 2009 Feb 15;61(2):209-15. doi: 10.1002/art.24097.

2.

Use of a case manager to improve osteoporosis treatment after hip fracture: results of a randomized controlled trial.

Majumdar SR, Beaupre LA, Harley CH, Hanley DA, Lier DA, Juby AG, Maksymowych WP, Cinats JG, Bell NR, Morrish DW.

Arch Intern Med. 2007 Oct 22;167(19):2110-5.

PMID:
17954806
3.

HipWatch: osteoporosis investigation and treatment after a hip fracture: a 6-month randomized controlled trial.

Davis JC, Guy P, Ashe MC, Liu-Ambrose T, Khan K.

J Gerontol A Biol Sci Med Sci. 2007 Aug;62(8):888-91.

PMID:
17702881
4.

Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial.

Curtis JR, Westfall AO, Allison J, Becker A, Melton ME, Freeman A, Kiefe CI, MacArthur M, Ockershausen T, Stewart E, Weissman N, Saag KG.

Arch Intern Med. 2007 Mar 26;167(6):591-6.

PMID:
17389291
5.

A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture.

Majumdar SR, Rowe BH, Folk D, Johnson JA, Holroyd BH, Morrish DW, Maksymowych WP, Steiner IP, Harley CH, Wirzba BJ, Hanley DA, Blitz S, Russell AS.

Ann Intern Med. 2004 Sep 7;141(5):366-73.

PMID:
15353428
6.

Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician education.

Solomon DH, Katz JN, Finkelstein JS, Polinski JM, Stedman M, Brookhart MA, Arnold M, Gauthier S, Avorn J.

J Bone Miner Res. 2007 Nov;22(11):1808-15.

7.

Nurse case-manager vs multifaceted intervention to improve quality of osteoporosis care after wrist fracture: randomized controlled pilot study.

Majumdar SR, Johnson JA, Bellerose D, McAlister FA, Russell AS, Hanley DA, Garg S, Lier DA, Maksymowych WP, Morrish DW, Rowe BH.

Osteoporos Int. 2011 Jan;22(1):223-30. doi: 10.1007/s00198-010-1212-7. Epub 2010 Apr 1.

PMID:
20358359
8.
9.

Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.

Skordis N, Ioannou YS, Kyriakou A, Savva SC, Efstathiou E, Savvides I, Christou S.

Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:144-8.

PMID:
19337169
10.
11.

Slowing of bone loss in patients with rheumatoid arthritis by long-term high-intensity exercise: results of a randomized, controlled trial.

de Jong Z, Munneke M, Lems WF, Zwinderman AH, Kroon HM, Pauwels EK, Jansen A, Ronday KH, Dijkmans BA, Breedveld FC, Vliet Vlieland TP, Hazes JM.

Arthritis Rheum. 2004 Apr;50(4):1066-76.

12.

[Clinic effect of alendronate sodium treatment in osteoporosis patients with hip fracture].

Qiu GX, Wu ZH, Shen JX, Luo XZ, Tang H, Wang YP, Weng XS, Yang XY, Lin J, Jin J, Zhao H, Tian Y, Zhang JG.

Zhonghua Wai Ke Za Zhi. 2004 Mar 22;42(6):347-50. Chinese.

PMID:
15144688
13.

Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.

Giusti A, Barone A, Pioli G, Girasole G, Siccardi V, Palummeri E, Bianchi G.

Nephrol Dial Transplant. 2009 May;24(5):1472-7. doi: 10.1093/ndt/gfn690. Epub 2008 Dec 15.

PMID:
19075192
14.

Osteoporosis case manager for patients with hip fractures: results of a cost-effectiveness analysis conducted alongside a randomized trial.

Majumdar SR, Lier DA, Beaupre LA, Hanley DA, Maksymowych WP, Juby AG, Bell NR, Morrish DW.

Arch Intern Med. 2009 Jan 12;169(1):25-31. doi: 10.1001/archinte.169.1.25.

PMID:
19139320
16.

Postfracture care for older women: gaps between optimal care and actual care.

Metge CJ, Leslie WD, Manness LJ, Yogendran M, Yuen CK, Kvern B; Maximizing Osteoporosis Management in Manitoba Steering Committee.

Can Fam Physician. 2008 Sep;54(9):1270-6.

17.

Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults: regional variation and determinants of use in Quebec.

Vanasse A, Dagenais P, Niyonsenga T, Grégoire JP, Courteau J, Hemiari A.

BMC Musculoskelet Disord. 2005 Jun 21;6:33.

18.

Redefining osteoporosis treatment: Who to treat and how long to treat.

Lewiecki EM, Silverman SL.

Arq Bras Endocrinol Metabol. 2006 Aug;50(4):694-704. Review.

19.

Redesigning the care of fragility fracture patients to improve osteoporosis management: a health care improvement project.

Harrington JT, Barash HL, Day S, Lease J.

Arthritis Rheum. 2005 Apr 15;53(2):198-204.

20.

Effect of pamidronate on bone loss after kidney transplantation: a randomized trial.

Walsh SB, Altmann P, Pattison J, Wilkie M, Yaqoob MM, Dudley C, Cockwell P, Sweny P, Banks LM, Hall-Craggs M, Noonan K, Andrews C, Cunningham J.

Am J Kidney Dis. 2009 May;53(5):856-65. doi: 10.1053/j.ajkd.2008.11.036.

PMID:
19393473

Supplemental Content

Support Center